Race against deadly hospital pneumonia: new antibiotic combo enters final testing
NCT ID NCT07327619
Summary
This study is testing whether a new combination of antibiotics (meropenem + pralurbactam) works as well as an existing treatment (ceftazidime + avibactam) for serious pneumonia that patients get in hospitals or while on ventilators. It will involve about 420 adults with these infections. Researchers will compare how many patients survive by day 14 and monitor safety to see if the new combination is a good alternative treatment option.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HOSPITAL-ACQUIRED BACTERIAL PNEUMONIA AND VENTILATOR-ASSOCIATED BACTERIAL PNEUMONIA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hunan University Of Medicine General Hospital
RECRUITINGHuaihua, Hunan, 418000, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.